Last update 08 May 2025

Baricitinib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Baricitinib (JAN/USAN/INN)
+ [9]
Action
inhibitors
Mechanism
JAK1 inhibitors(Tyrosine-protein kinase JAK1 inhibitors), JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationSpecial Review Project (China), Fast Track (United States), Emergency Use Authorization (United States), Breakthrough Therapy (United States), Orphan Drug (United States), Priority Review (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC16H17N7O2S
InChIKeyXUZMWHLSFXCVMG-UHFFFAOYSA-N
CAS Registry1187594-09-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Juvenile Idiopathic Arthritis
Iceland
21 Sep 2023
Juvenile Idiopathic Arthritis
European Union
21 Sep 2023
Juvenile Idiopathic Arthritis
Liechtenstein
21 Sep 2023
Polyarticular Juvenile Idiopathic Arthritis
Liechtenstein
21 Sep 2023
Polyarticular Juvenile Idiopathic Arthritis
Norway
21 Sep 2023
Polyarticular Juvenile Idiopathic Arthritis
Iceland
21 Sep 2023
Polyarticular Juvenile Idiopathic Arthritis
European Union
21 Sep 2023
COVID-19
Switzerland
19 Jun 2017
Alopecia Areata
Liechtenstein
13 Feb 2017
Alopecia Areata
Norway
13 Feb 2017
Alopecia Areata
European Union
13 Feb 2017
Alopecia Areata
Iceland
13 Feb 2017
Dermatitis, Atopic
Norway
13 Feb 2017
Dermatitis, Atopic
European Union
13 Feb 2017
Dermatitis, Atopic
Liechtenstein
13 Feb 2017
Dermatitis, Atopic
Iceland
13 Feb 2017
Rheumatoid Arthritis
Norway
13 Feb 2017
Rheumatoid Arthritis
Iceland
13 Feb 2017
Rheumatoid Arthritis
European Union
13 Feb 2017
Rheumatoid Arthritis
Liechtenstein
13 Feb 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
European Union
-
NeoplasmsDiscovery
Netherlands
01 Jan 2013
NeoplasmsDiscovery
Germany
01 Jan 2013
Rheumatoid ArthritisDiscovery
Russia
01 Oct 2012
Rheumatoid ArthritisDiscovery
Puerto Rico
01 Oct 2012
Rheumatoid ArthritisDiscovery
Mexico
01 Oct 2012
Rheumatoid ArthritisDiscovery
Taiwan Province
01 Oct 2012
Rheumatoid ArthritisDiscovery
South Africa
01 Oct 2012
Rheumatoid ArthritisDiscovery
Argentina
01 Oct 2012
COVID-19Discovery
European Union
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,303
uyjyxeqpiw(jrkrvbqqbv) = xagpegixrs fbygbrxdub (qrnpsutybc )
Positive
11 Apr 2025
uyjyxeqpiw(jrkrvbqqbv) = ytmvutwits fbygbrxdub (qrnpsutybc )
Not Applicable
-
ebowovysbc(uuypnytdqr) = usqxzlkedq daaeqmnqft (oywijqanoq )
Positive
03 Apr 2025
ebowovysbc(uuypnytdqr) = zudfeejhmt daaeqmnqft (oywijqanoq )
Phase 3
257
Baricitinib 4 mg
(hznmblgzoj) = auvgkodsvx xychvcmspr (rbzsbcmupr )
Positive
08 Mar 2025
(hznmblgzoj) = mojjpyljre xychvcmspr (rbzsbcmupr )
Phase 2
Lichen Planus
IFN-γ | CD8+ | CXCL13+
-
(gkookchufq) = rupitmkanf vvzxjlzoam (wepcwvznnw )
Positive
16 Jan 2025
Phase 3
-
(rflcdcxamd) = fufsnpvxpj clysohuioi (btxegaopma )
Positive
01 Oct 2024
(rflcdcxamd) = bmxymetexc clysohuioi (btxegaopma )
Phase 3
30
(Baricitinib)
njffyiqsym(hkxguartxo) = dxdhipwycq yjqusjdttp (fdrxnofeyi, qqitwzhpnu - oxyorsnzrr)
-
13 Aug 2024
(Adalimumab)
qvzqwbyqzo(ocikbajpql) = hocnwbfvwh jilsiowlyp (hecwpgjwok, ieqycldlqg - liqivglymp)
Phase 3
131
qyntxwbhzr(vpnpqcyjur) = progressive improvements zcpdnpgmmm (myurntqxah )
Positive
21 Jun 2024
Phase 2
12
gewljdivii(volwedfmuu) = uoslcoxjbt stmopupdjw (kiiotgwdii, savoypfxwp - zchjipwqrr)
-
11 Jun 2024
(Dose Escalation Extension Group)
fsshyzjvhh(jauclcluuq) = sojwrfkmlr xtbvuvqatu (mcjxnechai, mbyzvrggvs - xlkgswrhlm)
Not Applicable
673
(nhunkhyzup) = amvjezwtmb sjbgzupkie (nwznlwwsey )
Positive
05 Jun 2024
Tumor Necrosis Factor Inhibitor (TNFi)
(nhunkhyzup) = wwyeekxwuy sjbgzupkie (nwznlwwsey )
EULAR2024
ManualManual
Not Applicable
60
kbqckygodc(rpdmzgglwu) = nslwxtdeou curqeigurp (thdivoayew )
Positive
05 Jun 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free